NCT01637493 Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients Status UNKNOWN Phase PHASE1
NCT01624805 Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome Status RECRUITING Phase PHASE2
NCT01594918 Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE1
NCT01557959 Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01541072 Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation Status TERMINATED Phase NA
NCT01533207 Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Status TERMINATED Phase PHASE3
NCT01498588 Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer Status TERMINATED Phase PHASE2
NCT01491841 IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1
NCT01355705 Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT01319981 Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT01313884 Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma Status TERMINATED Phase PHASE2
NCT01266447 Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer Status COMPLETED Phase PHASE2
NCT01256398 Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT01172912 High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy Status UNKNOWN Phase PHASE2
NCT01169636 Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT01126190 Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel Status COMPLETED Phase PHASE3